Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery

Similar documents
Andrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD

CLINICAL SCIENCES. Results After Lens Extraction in Patients With Diabetic Retinopathy. Early Treatment Diabetic Retinopathy Study Report Number 25

Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

A retrospective nonrandomized study was conducted at 3

Clinical Evaluation of the BunnyLens IOL

OCT Assessment of the Vitreoretinal Relationship in CSME

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome

Original Article. Authors

Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema

Prophylaxis of Macular edema with Peroperative Intravitreal Bevacizumab in Diabetic Retinopathy Patients Undergoing Phacoemulsification

Long-Term Prognosis of Extracapsular Cataract Extraction and Intraocular Lens Implantation in Diabetic Patients

Optometric Postoperative Cataract Surgery Management

Clinically Significant Macular Edema (CSME)

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion

Changes in Peripapillary Retinal Nerve Fiber Layer Thickness after Pattern Scanning Laser Photocoagulation in Patients with Diabetic Retinopathy

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Visual Outcomes after Cataract Surgery in Diabetic Patients: A Meta-Analysis

COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY

Diabetic Retinopathy and Peripapillary Retinal Thickness

EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA

Cataract is a major problem for diabetic patients

Optical Coherence Tomography Fast versus Regular Macular Thickness Mapping in Diabetic Retinopathy

Visual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes

The Human Eye. Cornea Iris. Pupil. Lens. Retina

The Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR

INTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76

Full-thickness Sclerotomy for Uveal Effusion Syndrome

Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema

CLINICAL SCIENCES. Repeatability and Reproducibility of Fast Macular Thickness Mapping With Stratus Optical Coherence Tomography

Subclinical Diabetic Macular Edema Study

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy

Clinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.

Progression of diabetic retinopathy after cataract extraction

In its initial report, the Early Treatment Diabetic Retinopathy. A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data

Efficacy of intravitreal bevacizumab (Avastin TM ) for shortterm treatment of diabetic macular edema

INTRODUCTION J. DAWCZYNSKI, E. KOENIGSDOERFFER, R. AUGSTEN, J. STROBEL. Department of Ophthalmology, University Hospital Jena, Jena - Germany

Vitrectomy Combined with Phacoemulsification and Intraocular Lens Implantation for Diabetic Macular Edema

Vitrectomy Combined with Intravitreal Triamcinolone Acetonide Injection and Macular Laser Photocoagulation for Nontractional Diabetic Macular Edema

Optical coherence tomography in diabetic macular edema: patterns and related risk factors

ILUVIEN IN DIABETIC MACULAR ODEMA

Visual outcome after phacoemulsification and IOL implantation in diabetic patients

R&M Solutions

Rama Vadapalli * 1, Vankadara Naga Suresh 2. Online Access and Article Informtaion. Original Research Article

New Developments in the treatment of Diabetic Retinopathy

Influence of cataract on image quality and macular thickness measured using spectral domain optical coherence tomography: a prospective cohort study

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

Diabetic Retinopathy A Presentation for the Public

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Kyungmin Lee, Heeyoung Chung, Youngsuk Park, Joonhong Sohn. HanGil Eye Hospital, Incheon, Korea

Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema

Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience

ORIGINAL ARTICLE. HIGH VOLUME CAMP SURGERIES A CLINICAL STUDY D. N. Prakash, K, Sathish, Sankalp Singh Sharma, Soujanya. K, Savitha Patil.

Electronic poster presentations

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Vitrectomy for Diabetic Cystoid Macular Edema

Fundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:


Incidence and Risk Factors of Cystoid Macular Edema after Vitrectomy with Silicone Oil Tamponade for Retinal Detachment

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

Diabetic Retinopatathy

VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT

Cataract and Diabetic macular edema: What should I do?

Intravitreal bevacizumab for pediatric exudative retinal diseases

Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity

CSME BCVA. OCT Bevacizumab CMT CMT BCVA. BCVA LogMAR. p CMT NPDR PDR PDR. Bevacizumab PDR FDA. Ranibizumab. Bevacizumab.

Structural changes of the anterior chamber following cataract surgery during infancy

Keat Ween Khaw 1*, Hee Hong Lam 1, Tsung Fei Khang 2, Azida Juana Wan Ab Kadir 1 and Visvaraja Subrayan 1

Bharati Vidyapeeth Deemed University, Medical College, School of Optometry, Dhanakwadi, Pune, Maharashtra, India 2

Ophthalmology Macular Pathways

JMSCR Vol 06 Issue 12 Page December 2018

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

Diabetic retinopathy (DR) progressively

Subnormal Vision in Uneventful Cataract Surgery after 6 Weeks Hospital Based Study

Diabetic Retinopathy Clinical Research Network

Accuracy of Biometry for Intraocular Lens Implantation Using the New Partial Coherence Interferometer, AL-scan

DIABETIC RETINOPATHY IS

Paradigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor

Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant

POSTERIOR SUBTENON INJECTION OF TRIAMCINALONE ACETONIDE FOR CYSTOID DIABETIC MACULAR EDEMA

Abstract. Introduction. Original paper. Comparison of screening for diabetic retinopathy by non-specialists and specialists

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Diabetic Retinopathy Clinical Research Network

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

PART 1: GENERAL RETINAL ANATOMY

Scleral Buckling Using a Non-contact Wide-Angle Viewing System with a 25-Gauge Chandelier Endoilluminator

1. Introduction. Correspondence should be addressed to Alfredo Niro;

Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

Recurrent intraocular hemorrhage secondary to cataract wound neovascularization (Swan Syndrome)

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Audit of Macular Hole Surgery, Visual Outcome Prediction on OCT Appearance of Macular Hole

The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema

University of Bristol - Explore Bristol Research

Moncef Khairallah, MD

A Patient s Guide to Diabetic Retinopathy

Quantitative Reduction in Central Foveal Thickness After First Anti-VEGF Injection as a Predictor of Final Outcome in BRVO Patients

Transcription:

pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(4):238-242 DOI: 10.3341/kjo.2011.25.4.238 Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery Original Article Soon Il Kwon, Duck Jin Hwang, Ji Young Seo, In Won Park Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea Purpose: To assess the macular thickness changes after cataract surgery in diabetic patients using optical coherence tomography (OCT). Methods: We retrospectively reviewed the records of 104 diabetic patients who underwent cataract surgery. We examined the changes of macular thickness using OCT before cataract surgery and 1 week, 1-, 2- and 6-months after surgery. The central subfield mean thickness (CSMT) was used to evaluate macular edema which was defined as an increase of CSMT (ΔCSMT) > 30% from the baseline. The association between prior laser treatment or severity of diabetic retinopathy and macular thickness were also analyzed. Results: Macular edema occurred in 19 eyes (18%) from the diabetic group and 63% of macular edema developed at 1 month after surgery. Thirteen (68%) out of 19 eyes with macular edema showed the resolution of macular edema by 6 months after surgery without treatment. ΔCSMT of eyes without a history of laser treatment was statistically greater compared to eyes with a history of laser treatment in at 1- and 2-months after surgery, but was not different than eyes who had laser treatment at 6-months after surgery. The severity of diabetic retinopathy was not significantly correlated to macular edema, but there was statistical difference when patients who had a history of prior laser treatment were excluded. Conclusions: The incidence of macular edema after cataract surgery in diabetic patients was 18%. Its peak incidence was at 1 month post surgery and it resolved spontaneously in 68% of patients by 6 months post surgery. Prior laser treatment might prevent postoperative macular edema until 2 months after cataract surgery in diabetic patients. However, macular edema did not affect the severity of diabetic retinopathy. Key Words: Cataract extraction, Diabetic retinopathy, Macular edema, Macular thickness Macular edema is a common cause of unfavorable visual outcome after cataract surgery. Clinically significant cystoid macular edema (CSME) has a reported incidence of 1% to 2% after cataract surgery [1]. Diabetes has been associated with an increased incidence of postoperative macular edema. The incidence of macular edema on optical coherence tomography (OCT) was 22% in diabetic eyes undergoing cataract surgery [2]. The macular edema after cataract surgery in diabetic patients could be caused by the cataract surgery or diabetes itself, but it might be hard to differentiate between these two causes. Received: October 8, 2010 Accepted: December 15, 2010 Corresponding Author: In Won Park, MD, PhD. Department of Ophthalmology, Hallym University Sacred Heart Hospital, #896 Pyeongchon-dong, Anyang 431-070, Korea. Tel: 82-31-380-3835, Fax: 82-31-380-3837, E-mail: piw@korea.com OCT has been shown to be highly reproducible in measuring macular thickness in normal individuals and diabetic patients [3,4]. For detecting macular edema, OCT is superior to contact lens biomicroscopy and as effective as fluorescein angiography (FAG) [5]. Since OCT can assess macular thickness quantitatively, it can detect subtle changes of macular thickness and is especially useful in mild cases. In a previous report, diabetic eyes with CSME at the time of cataract surgery showed persistent CSME throughout the first postoperative year and showed no tendency to resolve spontaneously [6]. For diabetic eyes without CSME at the time of cataract surgery, macular edema after cataract surgery resolved spontaneously in 50% of cases by 6 months and in 75% of cases by 1 year. However, a relatively small number of patients (n = 32) were enrolled in this study and it would be even smaller if the eyes with CSME at the time of surgery were excluded. Therefore, this is not enough evidence to determine the natural history of macular edema after c 2011 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 238

SI Kwon, et al. Diabetic Macula Edema after Cataract Surgery cataract surgery. Moreover, the macular edema was assessed by FAG in this study and it is difficult to detect subtle changes of macular thickness using FAG. In this study, we assessed the changes of macular thickness in diabetic patients after cataract surgery using OCT and also examined the influence of preoperative laser treatment and severity of diabetic retinopathy on macular thickness. Materials and Methods We reviewed the records of the patients with type 2 diabetes mellitus who underwent phacoemulsification with intraocular lens insertion between January 2008 and December 2008. A total of 104 eyes from 104 subjects were enrolled. Patients were excluded from the study if they had any of the following conditions: prior or concomitant surgery to the eye scheduled for cataract extraction such as vitreous surgery or glaucoma surgery, intraoperative complications, a history of macular edema within 6 months before the preoperative exam, a history of ocular and systemic conditions known to be associated with potentially irreversible significant vision loss, presence of any retinal or choroidal disease other than diabetes that could affect retinal thickness, and less than 6 months of follow-up care. Meanwhile, we included patients who had undergone laser photocoagulation for macular edema or for proliferative diabetic retinopathy (PDR) more than 6 months prior to surgery. Cataract surgery was performed by one single surgeon (IWP). A limbal incision or clear corneal incision was made, and continuous curvilinear capsulorrhexis was performed. For cataract surgery, phacoemulsification equipment (Legacy; Alcon Laboratories Inc., Fort Worth, TX, USA) was used. The nucleus was divided and phacoemulsification and aspiration were performed after cortical aspiration, an acrylic foldable IOL (Sensar AR40e; AMO, Santa Ana, CA, USA) was inserted in the capsular bag. Preoperative and postoperative examinations including best-corrected visual acuity using standard Korean visual acuity chart (Han s chart), which was translated into a logarithm of the minimal angle of resolution (logmar) scale for analysis purposes, slit-lamp examination, fundus photography and intraocular lens implantation were checked at every follow-up visit. All patients were followed at 1 week, 1-, 2-, 3- and 6-months after surgery. OCT was performed using commercially available equipment (software 3.0; Carl Zeiss Meditec, Dublin, CA, USA). After pupil dilation, a macular thickness map was generated. This standard OCT protocol uses six radially oriented scan lines to produce a topographical map of the macula and the mean value of 128 thickness values obtained in the central subfield, which is circular area of diameter 1 mm centered around the center point (central subfield mean thickness), was measured [7]. Central subfield mean thickness (CSMT) was evaluated every follow-up and we manually calculated the difference in the thickness (absolute change in thickness; ΔCSMT) from the baseline. We used the ΔCSMT to analyze the course of the macular edema because of the wide range of normal macular thickness. Macular edema was defined as 30% or more increase of CSMT from preoperative thickness determined by OCT [2]. In addition, the influence of prior laser treatment and severity of diabetic retinopathy on macular thickness was also analyzed. Study participants were divided based on the presence or absence of a history of photocoagulation (panretinal photocoagulation, focal or grid laser) and divided into 5 groups based on the severity of diabetic retinopathy (no diabetic retinopathy, mild-, moderate-, severe non-proliferative diabetic retinopathy [NPDR], and PDR). The absolute change in macular thickness and the change of visual acuity were calculated at every follow-up after surgery and analyzed among comparative groups. Statistical analysis was performed by SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics, including mean and standard deviation were calculated for each group. Group comparisons were performed using the student t-test. Fisher s exact, two-tailed test was used for analysis of data on a nominal scale. A p-value less than 0.05 was considered statistically significant. Results The 104 subjects in this series were made up of 36 men and 68 women and their mean age was 68.21 ± 9.09 years. Mean preoperative best-corrected visual acuity in logmar units was 0.57 ± 0.47 and mean preoperative CSMT was 164.42 ± 25.02 µm. The number of patients without diabetic retinopathy were 61 (58.65%), with mild to moderate NPDR were 27 (25.96%), with severe NPDR or PDR were 16 (15.36%). Postoperative complications occurred in 39 eyes (37.5%). Table 1. Demographics Demographics Eyes (n) 104 Sex (male:female) 36:68 Age (yr) 68.21 ± 9.09 SE (diopter) 1.25 ± 0.68 Preoperative BCVA (logmar) 0.57 ± 0.47 Preoperative CSMT 164.42 ± 25.02 Diabetic retinopathy stage No diabetic retinopathy 61 (58.65%) Mild to moderate NPDR 27 (25.96%) Severe NPDR or PDR 16 (15.38%) Postoperative complications Macular edema 19 (18.27%) IOP elevation 5 (4.81%) Vitreous hemorrhage 2 (1.92%) Posterior capsular opacity 1 (0.96%) Retinopathy progression 12 (11.54%) BCVA = best corrected visual acuity; logmar = logarithm of the minimal angle of resolution; CSMT = central subfield macular thickness; NPDR = non proliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy; IOP = intraocular pressure. 239

Korean J Ophthalmol Vol.25, No.4, 2011 The most common complication was macular edema, which were occurred in 19 eyes (18.27%), followed by retinopathy progression (11.54%), elevation of intraocular pressure, vitreous hemorrhage, and posterior capsular opacity (Table 1). Among the 19 eyes with macular edema, 12 eyes (63%) developed macular edema at 1 month after surgery, and 13 eyes (68%) showed improvement of macular edema by 6 months after surgery (Fig. 1). The remaining 6 eyes did not improve by 6 months and were followed for more than 1 year. Three eyes improved macular edema at 7, 8 and 12 months, 2 eyes were treated with intravitreal triamcinolone acetonide at 12 months, and 1 patient did not visit at 1 year after surgery. We explored the changes of macular thickness (ΔCSMT) using OCT. Because the laser photocoagulation could affect on macular thickness, the diabetic patients were divided into a laser group, which were patients who had a history of any photocoagulation, and a non-laser group, which were patients who had not had photocoagulation. Of the 104 diabetic Fig. 1. The total and newly developed number of patients with macula edema after cataract surgery. patients, 14 had a history of photocoagulation (12 with panretinal photocoagulation, 2 with focal laser). There were no statistical differences in baseline characteristics except the severity of diabetic retinopathy (Table 2). After cataract surgery, it seemed that the incidence of macular edema and progression of retinopathy increased in the non-laser group compared to the laser group, although it was not statistically significant. Compared to the laser group, ΔCSMT of the non-laser group was statistically significant at 1 and 2 months after surgery. ΔCSMT was greatest at 1 month post surgery and gradually decreased in both groups thereafter (Fig. 2A). Similarly, ΔCSMT of the eye with macular edema (19 eyes) was greatest at 1 month after surgery and gradually decreased by 6 months, but was still significantly increased compared to the eyes without macular edema (Fig. 2B). The changes of visual acuity (ΔlogMAR), which was not statistically significant between laser and non-laser groups, constantly improved in both groups (Fig. 3A). The visual acuity of the eyes without macular edema constantly improved for 6 months after surgery. However, the visual acuity of the eyes with macular edema showed little improvement until 1 month after surgery and only improved after 2 months post surgery (Fig. 3B). Fifteen (79%) out of 19 patients with macular edema improved more than 0.1 logmar, and 10 patients (53%) achieved logmar of 0.1 or less ( 20 / 20) at 6 months after surgery. Severity of diabetic retinopathy was not significantly correlated to macular edema (p = 0.116). Since the laser treatment could affect macular thickness and confuse the interpretation of the results, we re-evaluated the correlation between severity of diabetic retinopathy and changes of macular thickness after patients who had prior laser treatment were excluded. We found that there was statistical difference in macular thickness through severity of diabetic retinopathy after exclusion of these patients (p = 0.017). Table 2. Characteristics of diabetic patients according to the history of laser treatment Non-laser group Laser group p-value Demographics Eyes (n) 90 14 Sex (male:female) 31:59 5:9 Age (yr) 69.46 ± 8.41 60.21 ± 9.54 >0.05 * SE (diopter) 1.25 ± 0.76 1.22 ± 0.52 >0.05 * Preop BCVA 0.56 ± 0.47 0.66 ± 0.4 >0.05 * Preop CSMT 163.16 ± 26.09 172.50 ± 23.43 >0.05 * Incidence of macular edema 18 (20%) 1 (7.14%) 0.457 Diabetic retinopathy stage No diabetic retinopathy 61 (67.78%) 0 (0%) Mild to moderate NPDR 25 (27.78%) 2 (14.29%) Severe NPDR or PDR 4 (4.44%) 12 (85.71%) Retinopathy progression 11 (12.22%) 1 (7.14%) 0.699 BCVA = best corrected visual acuity; CSMT = central subfield macular thickness; NPDR = non proliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy. * Student t-test (p < 0.05). Fisher s exact test (p < 0.05). 240

SI Kwon, et al. Diabetic Macula Edema after Cataract Surgery A B Fig. 2. The changes of central subfield macular thickness in eyes with and without prior laser treatment (A) and in eyes with and without macular edema (B) after cataract surgery. POD = postoperative day; ME = macular edema. * Student t-test (p < 0.05). A B Fig. 3. The changes of best corrected visual acuity in eyes with and without prior laser treatment (A) and in eyes with and without macular edema (B) after cataract surgery. logmar = logarithm of the minimal angle of resolution; ME = macular edema. * Student t-test (p < 0.05). Discussion Macular edema after cataract surgery in diabetic patients could be caused by the cataract surgery (Irvine-Gass syndrome) or diabetes itself. Most of the macular edema after cataract surgery resolves spontaneously by 6 months, but diabetic macular edema tends to persist [8,9]. Therefore, it is recommended that laser therapy for macular edema be deferred until 6 months after surgery to permit resolution of the Irvine-Gass element [9]. Dowler et al. [6] reported that CSME arising after surgery commonly resolved, particularly if retinopathy was mild. CSME occurred in half of the eyes in which CSME was absent at the time of surgery, with a peak incidence at 6 weeks. It resolved spontaneously by 6 months in half of the eyes affected and by 1 year in three quarters of the affected eyes. In our study, macular edema occurred in 19 eyes (18%) and improved spontaneously by 6 months in 68% of eyes. Its peak incidence was at 1 month post surgery, which is similar compared to previous reports. However, the incidence of macular edema appears to be rather low compared to previous studies, which reported incidence rates of 29% to 56% and the proportion of improvement is slightly higher [6,10,11]. One explanation for this result might be that patients with previous laser treatment such as panretinal photocoagulation or laser treatment for macular edema were not excluded in our study. Early Treatment Diabetic Retinopathy Study (ETDRS) [12] reported that prior photocoagulation might be the reason for relatively good visual results and photocoagulation in patients with severe NPDR or CSME should be considered before lens surgery. They also recommended that photocoagulation be considered before lens surgery in patients with severe NPDR or CSME when possible [13]. The eyes without a history of laser therapy showed a statistically significant increase in CSMT at 1 and 2 months after surgery compared to eyes with previous laser therapy. However, there was no statistical difference between the two groups at 6 months post surgery. From these results we could assume that prior laser treatment could lower the risk for early postoperative macular edema until 2 months after surgery, but there would be little influence of the previous laser therapy on macular thickness 6 months post surgery. ETDRS [10] reported that they did not observe an increased rate of macular edema after lens surgery. It is possible that the photocoagulation performed before surgery may have had a protective effect on the development of postoperative macular edema [14]. However, they assessed the rates of macular edema at 4-months after surgery. Thus, an accelerated rate of 241

Korean J Ophthalmol Vol.25, No.4, 2011 macular edema development immediately after surgery cannot be ruled out. We presumed that early postoperative macular edema is due mostly to the Irvine-Gass component. On the contrary, the improvement of visual acuity was not related to the history of laser treatment and the visual acuity improved even in eyes with macular edema at 6 months after surgery. There was no significant difference in visual acuity between the eyes with and without macular edema after 2 months post surgery, although macular edema still remained as seen in the OCT. This result suggests that macular edema could be managed conservatively in diabetic patients. In conclusion, this study demonstrated that 18% of diabetic patients developed increases in CSMT > 30% after cataract surgery. Its peak incidence was at 1 month post surgery and it resolved spontaneously in 68% of patients by 6 months post surgery. This suggests that macular edema after cataract surgery in diabetic patients could be managed conservatively because it is likely to improve without treatment by 6 months post surgery, although prior laser treatment could lower the risk of early postoperative macular edema. Conflict of Interest No potential conflict of interest relevant to this article was reported. References 1. Wright PL, Wilkinson CP, Balyeat HD, et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 1988;106:740-4. 2. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114:881-9. 3. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-29. 4. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759-67. 5. Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004;111:712-5. 6. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663-8. 7. Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-71, 1371.e1. 8. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966;76:646-61. 9. Benson WE. Cataract surgery and diabetic retinopathy. Curr Opin Ophthalmol 1992;3:396-400. 10. Funatsu H, Yamashita H, Noma H, et al. Prediction of macular edema exacerbation after phacoemulsification in patients with nonproliferative diabetic retinopathy. J Cataract Refract Surg 2002;28:1355. 11. Krepler K, Biowski R, Schrey S, et al. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 2002;240:735-8. 12. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-806. 13. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol 1992;76:221-4. 14. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999;117:1600-6. 242